Urology Center of Englewood

Latest Clinical News

FDA Approves New Imaging Agent for Detection of Recurrent Prostate Cancer (06-13-2016)
The United States Food and Drug Administration (FDA) has approved Axumin (fluciclovine F 18), an radioactive agent, to be used in positron emission tomography (PET) imaging for the detection of recurrent... Continue Reading

Tecentriq® Approved for Bladder Cancer (06-8-2016)
The United States Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) for the treatment of bladder cancer. Atezolizumab is an immunotherapy agent referred to as a PD-1/PD-L1 inhibitor,... Continue Reading

Tecentriq® Effective as Initial Therapy in Advanced Bladder Cancer (06-8-2016)
The immunotherapy agent Tecentriq® (atezolizumab) provides anti-cancer activity when used as initial therapy among patients with advanced bladder cancer who are not able to tolerate standard therapy.... Continue Reading

More News

Locations

Englewood
300 Grand Avenue, Suite 202
Englewood, NJ 07631
Phone: (201) 816-1900
Fax: (201) 816-1777
Click here for map

 

Cliffside Park
663 Palisade Ave. Suite 304
Cliffside Park, NJ 97010
Phone: (201) 313-1933
Fax: (201) 313-9599
Click here for map

 

Hospital Affiliations
Englewood Hospital Medical Center
Holy Name Hospital
Palisades Medical Center
Mt. Sinai Hospital (NYC)
Columbia – New York-Presbyterian